GB2092581A - 6-oxo-7-(dimethylaminomethylene)-decahydroquinolines - Google Patents

6-oxo-7-(dimethylaminomethylene)-decahydroquinolines Download PDF

Info

Publication number
GB2092581A
GB2092581A GB8203158A GB8203158A GB2092581A GB 2092581 A GB2092581 A GB 2092581A GB 8203158 A GB8203158 A GB 8203158A GB 8203158 A GB8203158 A GB 8203158A GB 2092581 A GB2092581 A GB 2092581A
Authority
GB
United Kingdom
Prior art keywords
mixture
oxo
alkyl
compound
dimethylaminomethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB8203158A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB2092581A publication Critical patent/GB2092581A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
GB8203158A 1979-01-22 1979-06-28 6-oxo-7-(dimethylaminomethylene)-decahydroquinolines Withdrawn GB2092581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506179A 1979-01-22 1979-01-22
US06/031,641 US4198415A (en) 1979-01-22 1979-04-19 Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
GB2092581A true GB2092581A (en) 1982-08-18

Family

ID=26673868

Family Applications (4)

Application Number Title Priority Date Filing Date
GB8203157A Expired GB2092580B (en) 1979-01-22 1979-06-28 6(oxo-or hydroxy-)decahydroquinolines
GB8203158A Withdrawn GB2092581A (en) 1979-01-22 1979-06-28 6-oxo-7-(dimethylaminomethylene)-decahydroquinolines
GB8203156A Withdrawn GB2092579A (en) 1979-01-22 1979-06-28 Octahydro pyrazolo (3,4-g) quinolines
GB7922530A Expired GB2040915B (en) 1979-01-22 1979-06-28 Octahydro pyrazol (3,4-g) quinolines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB8203157A Expired GB2092580B (en) 1979-01-22 1979-06-28 6(oxo-or hydroxy-)decahydroquinolines

Family Applications After (2)

Application Number Title Priority Date Filing Date
GB8203156A Withdrawn GB2092579A (en) 1979-01-22 1979-06-28 Octahydro pyrazolo (3,4-g) quinolines
GB7922530A Expired GB2040915B (en) 1979-01-22 1979-06-28 Octahydro pyrazol (3,4-g) quinolines

Country Status (25)

Country Link
US (1) US4198415A (US20100223739A1-20100909-C00005.png)
EP (2) EP0050881B1 (US20100223739A1-20100909-C00005.png)
AT (1) AT371819B (US20100223739A1-20100909-C00005.png)
AU (1) AU528076B2 (US20100223739A1-20100909-C00005.png)
CA (1) CA1136140A (US20100223739A1-20100909-C00005.png)
CH (3) CH644377A5 (US20100223739A1-20100909-C00005.png)
DD (5) DD148340A5 (US20100223739A1-20100909-C00005.png)
DE (2) DE2966951D1 (US20100223739A1-20100909-C00005.png)
DK (1) DK268879A (US20100223739A1-20100909-C00005.png)
EG (1) EG14696A (US20100223739A1-20100909-C00005.png)
ES (4) ES482091A1 (US20100223739A1-20100909-C00005.png)
FI (1) FI65247C (US20100223739A1-20100909-C00005.png)
FR (5) FR2446832A1 (US20100223739A1-20100909-C00005.png)
GB (4) GB2092580B (US20100223739A1-20100909-C00005.png)
GR (1) GR72516B (US20100223739A1-20100909-C00005.png)
IE (1) IE48394B1 (US20100223739A1-20100909-C00005.png)
IL (1) IL57668A (US20100223739A1-20100909-C00005.png)
LU (1) LU81439A1 (US20100223739A1-20100909-C00005.png)
MY (1) MY8500683A (US20100223739A1-20100909-C00005.png)
NZ (2) NZ190835A (US20100223739A1-20100909-C00005.png)
PH (3) PH14909A (US20100223739A1-20100909-C00005.png)
PL (4) PL119785B1 (US20100223739A1-20100909-C00005.png)
PT (1) PT69829A (US20100223739A1-20100909-C00005.png)
RO (2) RO77563A (US20100223739A1-20100909-C00005.png)
ZA (1) ZA793243B (US20100223739A1-20100909-C00005.png)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
US4540787A (en) * 1982-06-03 1985-09-10 Eli Lilly And Company Method of preparing trans-D1-1-alkyl-6-oxodecahydroquinolines
US4647667A (en) * 1982-11-03 1987-03-03 Eli Lilly And Company Octa- and deca-hydroquinoline intermediates
US4567266A (en) * 1982-11-03 1986-01-28 Eli Lilly And Company Method of preparing octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines
ES8504174A1 (es) * 1982-11-03 1985-04-16 Lilly Co Eli Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
US4471121A (en) * 1982-11-03 1984-09-11 Eli Lilly And Company Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof
US4468401A (en) * 1982-11-03 1984-08-28 Eli Lilly And Company Method of blocking peripheral norepinephrine release
DE3373468D1 (de) * 1983-06-03 1987-10-15 Lilly Co Eli Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
US4626591A (en) * 1983-08-10 1986-12-02 Eli Lilly And Company Trans-dl-1-alkyl-6-alkoxy-1,2,3,4,4a,5,8,8a octa-hydroquinolines
IL72729A (en) * 1983-09-26 1988-02-29 Lilly Co Eli Trans(+_)octahydropyrazole-ring alkylated pyrazoloquinolines,their preparation and pharmaceutical compositions containing them
US4528290A (en) * 1984-01-30 1985-07-09 Eli Lilly And Company Stimulating dopamine D-1 receptors
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4507478A (en) * 1983-09-26 1985-03-26 Eli Lilly And Company 2-Mercaptopyrimidohexahydroquinolines and related compounds
FI78091C (fi) * 1983-09-26 1989-06-12 Lilly Co Eli Analogifoerfarande foer framstaellning av saosom dopaminoagonister anvaendbara pyrimido/4,5-g/kinolinderivat.
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4501890A (en) * 1983-09-26 1985-02-26 Eli Lilly And Company Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines
US4689415A (en) * 1984-04-18 1987-08-25 Eli Lilly And Company Trans octahydroquinoline intermediate
US4587351A (en) * 1984-04-18 1986-05-06 Eli Lilly And Company Synthesis of ketones with calcium hypochlorite
US4537893A (en) * 1984-04-27 1985-08-27 Eli Lilly And Company Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors
IE58695B1 (en) * 1984-08-02 1993-11-03 Lilly Co Eli Octahydro-oxazolo [4,5-g] quinolines
US4600777A (en) * 1984-08-02 1986-07-15 Eli Lilly And Company Method of preparing 1-alkyl-7-oxodecahydroquinolines, and cis(±) and tran(±)isomers so prepared
US4537964A (en) * 1984-08-03 1985-08-27 Eli Lilly And Company Method of preparing permissibly-substituted 1H(and 2H)pyrazolo[3,4-g]quinolines; pyrimido[4,5,g]quinolines; thiazolo[4,5,g]quinolines and intermediates therefore
US4537965A (en) * 1984-08-03 1985-08-27 Eli Lilly And Company Method of preparing 4aR,8aR-5-permissibly substituted-6-oxo-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines, useful as intermediates
HUT40656A (en) * 1984-08-03 1987-01-28 Lilly Co Eli Process for producing tricyclic quinoline derivatives
US4587336A (en) * 1984-08-15 1986-05-06 Eli Lilly And Company Partially hydrogenated intermediate pyrazolo, pyrimido and thiazolo[1,4]benzoxazines
US4552956A (en) * 1984-08-15 1985-11-12 Eli Lilly And Company Partially hydrogenated pyrazolo, pyrimido and thiazolo[1,4]benzoxazines
FR2578254B1 (fr) * 1985-03-01 1987-03-06 Roussel Uclaf Nouveaux derives de la pyrazolobenzoxazine, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et des intermediaires
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4622398A (en) * 1985-06-24 1986-11-11 Eli Lilly And Company Dialkylaminotetrahydroquinazoline
US4977160A (en) * 1986-06-16 1990-12-11 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
US4826986A (en) * 1986-06-16 1989-05-02 Eli Lilly And Company 6-Oxo-trans-octa- and decahydroquinolines
US5134143A (en) * 1986-06-16 1992-07-28 Eli Lilly And Company BCD tricyclic ergoline part-structure analogues
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US4939259A (en) * 1989-07-24 1990-07-03 Eli Lilly And Company 2-oxo-pyrido[2,3-g]quinoline derivatives
US5057515A (en) * 1989-07-24 1991-10-15 Eli Lilly And Company Method for agonizing a dopamine receptor
US4977149A (en) * 1989-07-24 1990-12-11 Eli Lilly And Company Pyridoquinoline dopamine agonists, compositions and use
US5006525A (en) * 1989-07-24 1991-04-09 Eli Lilly And Company Dopamine agonists method
WO1992006079A1 (en) * 1990-09-28 1992-04-16 Pfizer Inc. Fused ring analogs of nitrogen containing nonaromatic heterocycles
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US20030212085A1 (en) * 2001-04-17 2003-11-13 Mccall Robert B. Treatment of fibromyalgia and chronic fatigue syndrome
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084165A (en) * 1959-05-21 1963-04-02 Bayer Ag Quinone derivatives and processes for producing the same
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
US3859291A (en) * 1973-10-01 1975-01-07 Morton Norwich Products Inc 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines

Also Published As

Publication number Publication date
PL120037B1 (en) 1982-02-27
LU81439A1 (fr) 1979-09-12
EP0050881A1 (en) 1982-05-05
FI792046A (fi) 1980-07-23
DD148517A5 (de) 1981-05-27
CH644377A5 (fr) 1984-07-31
DD148518A5 (de) 1981-05-27
GB2092580B (en) 1983-08-03
PL119715B1 (en) 1982-01-30
IE791209L (en) 1980-07-22
IL57668A (en) 1983-06-15
FR2446834A1 (fr) 1980-08-14
FI65247C (fi) 1984-04-10
ES482087A1 (es) 1980-04-01
PL119785B1 (en) 1982-01-30
DD148340A5 (de) 1981-05-20
AU4844579A (en) 1980-07-31
CH644365A5 (fr) 1984-07-31
ATA452479A (de) 1982-12-15
AU528076B2 (en) 1983-04-14
AT371819B (de) 1983-08-10
FR2446834B1 (US20100223739A1-20100909-C00005.png) 1982-03-05
GB2040915B (en) 1983-05-11
GR72516B (US20100223739A1-20100909-C00005.png) 1983-11-16
NZ201279A (en) 1984-07-06
PH14991A (en) 1982-03-12
PH14909A (en) 1982-01-29
ES482090A1 (es) 1980-04-01
DK268879A (da) 1980-07-23
FR2446821A1 (fr) 1980-08-14
PL216719A1 (US20100223739A1-20100909-C00005.png) 1980-06-16
CH644607A5 (fr) 1984-08-15
FR2446820A1 (fr) 1980-08-14
DD148339A5 (de) 1981-05-20
GB2092579A (en) 1982-08-18
RO82159B (ro) 1983-06-30
EP0013787B1 (en) 1984-05-02
ES482089A1 (es) 1980-08-01
GB2092580A (en) 1982-08-18
IL57668A0 (en) 1979-10-31
DE2966951D1 (en) 1984-06-07
FR2446822A1 (fr) 1980-08-14
EG14696A (en) 1986-09-30
FI65247B (fi) 1983-12-30
FR2446832A1 (fr) 1980-08-14
IE48394B1 (en) 1985-01-09
MY8500683A (en) 1985-12-31
PT69829A (en) 1979-07-01
ES482091A1 (es) 1980-04-01
EP0050881B1 (en) 1984-04-25
CA1136140A (en) 1982-11-23
PL122153B1 (en) 1982-06-30
PH14908A (en) 1982-01-29
US4198415A (en) 1980-04-15
GB2040915A (en) 1980-09-03
FR2446832B1 (US20100223739A1-20100909-C00005.png) 1983-08-05
FR2446822B1 (US20100223739A1-20100909-C00005.png) 1981-10-02
DE2966945D1 (de) 1984-05-30
DD144670A5 (de) 1980-10-29
RO77563A (ro) 1981-11-04
RO82159A (ro) 1983-07-07
NZ190835A (en) 1984-07-06
ZA793243B (en) 1981-02-25
EP0013787A1 (en) 1980-08-06

Similar Documents

Publication Publication Date Title
GB2092581A (en) 6-oxo-7-(dimethylaminomethylene)-decahydroquinolines
Chu et al. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents
US4808590A (en) Antiviral, antitumor and antifungal compositions and their methods of use
AT395150B (de) Verfahren zur herstellung von neuen benzoheterozyklischen verbindungen
RU1794079C (ru) Способ получени замещенных 7-амино-3-окси-1-карба(1-детиа)-3-цефем-4-карбоксилата в форме цис-энантиомера
GB2126580A (en) Heterocyclic oxyphenols
IL201850A (en) Preparation of carbonate and carbamate derivatives converted to quinoline
CA1109871A (en) Purine derivatives
Michel et al. Epipolythiopiperazinedione antibiotics from Penicillium turbatum
DE68924556T2 (de) N-(N-(Tetrahydropyrido[2,3-d]pyrimidinylmethyl)-aminomethylbenzoyl)glutaminsäure-Derivate.
IL95936A (en) ) R (-) - (- Hydroxy- (A-]]] 6-) 4- Phenylbutoxy (xyl [amino] methyl [-1,3-benzenedimethanol, its preparation and pharmaceutical preparations containing it
US4382936A (en) Cerebral vasodilator eburnane derivatives
US4882316A (en) Pyrimidine derivatives
CH644859A5 (de) Benzo(ij)chinolizin-2-carbonsaeuren und diese verbindungen enthaltende arzneimittel.
GB2083039A (en) Spectinomycin analogues and their preparation
Jinbo et al. Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterial agents. 2
DE3632893A1 (de) 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NZ204900A (en) 1,3-dioxolo(4,5-g)quinolines and pharmaceutical compositions containing such
SU1047391A3 (ru) Способ получени производных рифамицина
US4528372A (en) N-Phthalidyl-5-fluorouracils
IE48396B1 (en) 6(oxo-or hydroxy-)decahydroquinolines
US4668822A (en) Method for preparing (+)S-2--hydroxy-2-methyl-hexanoic acid
GB1603127A (en) Rifamycin compounds
US4801606A (en) Antiviral compositions
US4497816A (en) 7-(4-Pyridyl)-1,8-naphthyridine derivatives and their antibacterial compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)